{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T21:13:08Z","timestamp":1772226788916,"version":"3.50.1"},"reference-count":21,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"2","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/BY\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Biochemistry"],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:p>Background: Empyema is an infectious disease characterised by the accumulation of pus in the pleural space, accompanied by inflammation. Patients often present with fever, chest pain, dyspnea, or cough, and delayed diagnosis or treatment is associated with a high mortality rate. Therefore, in this study, we aimed to investigate the clinical utility of the Systemic Inflammation Response Index (SIRI), Pan-Immune Value (PIV), C-Reactive Protein (CRP)-Albumin-Lymphocyte (CALLY) index, and the Systemic Immune-Inflammation Index (SII) to assess the severity of empyema and predict mortality risk. Methods: Seventy-three patients diagnosed with empyema in the thoracic surgery clinic between January 2022 and October 2024 were included in the study. Patients were categorised based on their need for intensive care. Demographic and laboratory data (white blood cell count, platelet count, albumin levels, pleural fluid culture results, and C-reactive protein levels) were recorded. Differences between empyema patient groups classified according to disease severity were analysed. Results: Among the 73 patients included in our study, four deaths were recorded. The CALLY index could be used for intensive care and ward triage (p= 0.039). Although the SII and SIRI indices were not suitable for triage purposes, the SIRI index was found to help predict mortality (p= 0.01). Conclusions: In empyema cases, the CALLY index can be used to determine the need for intensive care, whereas the SIRI can help predict mortality risk.<\/jats:p>","DOI":"10.5937\/jomb0-57112","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T09:00:28Z","timestamp":1765789228000},"page":"386-393","source":"Crossref","is-referenced-by-count":0,"title":["Predictive value of haematological indices on mortality in patients with empyema"],"prefix":"10.5937","volume":"45","author":[{"suffix":"Kutta","given":"Ali","family":"\u00c7elik","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology Mogadishu-Somalia-Turkey Recep Tayyip Erdo an Training and Research Hospital, Mogadishu, Somalia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Ali","given":"Abdikani","family":"Salad","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery Mogadishu-Somalia-Turkey Recep Tayyip Erdo an Training and Research Hospital, Mogadishu, Somalia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Okke\u00a7","family":"Zortuk","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Hatay Defne State Hospital, Hatay, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3964","reference":[{"key":"ref1","unstructured":"Sharma S, Boster J. Malignant Pleural Effusion. StatPearls. Treasure Island (FL) StatPearls Publishing; 2024;"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. The Journal of thoracic and cardiovascular surgery 2017; 153(6): e129-e46;","DOI":"10.1016\/j.jtcvs.2017.01.030"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Light RW. A new classification of parapneumonic effusions and empyema. Chest 1995; 108(2): 299-301;","DOI":"10.1378\/chest.108.2.299"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Higuchi M, Suzuki HJCCiTS. Current status and prospect of medical and surgical management for thoracic empyema 2020. 2020; 2;","DOI":"10.21037\/ccts.2020.02.09"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Presti X Asghar A, Ravikumar N. Management of Pleural Infection: A Historical Review and Updates 2024; 4(2): 112-27;","DOI":"10.3390\/jor4020010"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Imburgio S, Tavakolian K, Mararenko A, et al. Empyema Versus Lung Abscess: A Case Report. J Investig Med High Impact Case Rep. 2022; 10: 23247096221139268;","DOI":"10.1177\/23247096221139268"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Heffner JE, Klein JS, Hampson C. Diagnostic utility and clinical application of imaging for pleural space infections. Chest 2010; 137(2): 467-79;","DOI":"10.1378\/chest.08-3002"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Pacheco-Barcia V, Mondejar Solis R, France T, et al. A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer. Pancreatology 2020; 20(2): 254-64;","DOI":"10.1016\/j.pan.2019.12.010"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Feng JF, Chen S, Yang X. Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus. Medicine (Baltimore) 2017; 96(4): e5886;","DOI":"10.1097\/MD.0000000000005886"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Kayhan S, Aydin sak O. The significance of pan-immune inflammation value and systemic immune inflammation Index in colorectal cancer screening. Turkish Journal of Clinics and Laboratory 2021; 12(3): 273-7;","DOI":"10.18663\/tjcl.985559"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Shivappa N, Hebert JR, Marcos A, et al. Association between dietary inflammatory index and inflammatory markers in the HELENA study. Molecular Nutrition & Food Research 2017; 61(6): 1600707;","DOI":"10.1002\/mnfr.201600707"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Pre-Treatment CRP-Albumin-Lymphocyte Index (CALLY Index) as a Prognostic Biomarker of Survival in Patients with Epithelial Ovarian Cancer. Cancer management and research 2022; Volume 14: 2803-12;","DOI":"10.2147\/CMAR.S359968"},{"key":"ref13","unstructured":"Tongchao J, Haishuang S, Shuyu X, et al. Significance of Pre-Treatment CALLY Score Combined with EBV-DNA Levels for Prognostication in Non-Metastatic Nasopharyngeal Cancer Patients: A Clinical Perspective. Journal of Inflammation Research 2024;"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Yao-Te T, Chien-An K, Hung-Chin C, et al. Prognostic Value of CRP-Albumin-Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Oral Cavity Cancer. Journal of Cancer 2022; 13(10): 3000-12;","DOI":"10.7150\/jca.74930"},{"key":"ref15","unstructured":"Ying IP Ting W, Changbo D, et al. Association between the C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index and Adverse Clinical Outcomes in CAD Patients after PCI: Findings of a Real-World Study. Reviews in Cardiovascular Medicine 2024;"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Yin X, Zhang Y Zou J, et al. Association of the systemic immune-inflammation index with all-cause and cardiovascular mortality in individuals with rheumatoid arthritis. Scientific Reports 2024; 14(1): 15129;","DOI":"10.1038\/s41598-024-66152-4"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Marchi F Pylypiv N, Parlanti A, et al. Systemic Immune-Inflammation Index and Systemic Inflammatory Response Index as Predictors of Mortality in ST-Elevation Myocardial Infarction 2024; 13(5): 1256;","DOI":"10.3390\/jcm13051256"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Topal A, Yarka\u00e7 A, Bozkurt S, et al. Prognostic importance of the systemic inflammatory index and the systemic inflammatory response index in COVID-19 patients. Emergency Care Journal 2024; 20(3);","DOI":"10.4081\/ecj.2024.12528"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Ren T, Zhou E, Wu J, et al. Systemic inflammation markers independently associated with increased mortality in individuals with hyperuricemia: Results from the NHANES prospective cohort study 2024; 12(10): e70032;","DOI":"10.1002\/iid3.70032"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Cespedes Feliciano EM, Kroenke CH, Meyerhardt JA, et al. Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the CSCANS Study. JAMA Oncology 2017; 3(12): e172319-e;","DOI":"10.1001\/jamaoncol.2017.2319"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Gu L, Xia Z, Qing B, et al. Systemic Inflammatory Response Index (SIRI) is associated with all-cause mortality and cardiovascular mortality in population with chronic kidney disease: evidence from NHANES (2001-2018) 2024; 15;","DOI":"10.3389\/fimmu.2024.1338025"}],"container-title":["Journal of Medical Biochemistry"],"original-title":["Prediktivna vrednost hematolo\u0161kih parametara na mortalitet kod pacijenata sa empijemom"],"language":"en","link":[{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2026\/1452-82582602386Q.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T20:43:20Z","timestamp":1772225000000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/Article.aspx?artid=1452-82582602386Q"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5937\/jomb0-57112","relation":{},"ISSN":["1452-8258","1452-8266"],"issn-type":[{"value":"1452-8258","type":"print"},{"value":"1452-8266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}